Trigger point injection

Speaker 1...so, we're talking about trigger point injections today, a common intervention for localized muscle pain. It’s essentially injecting into those taut bands of muscle.

Speaker 2Right. And the immediate goal is pain relief. But the connection to aging and all-cause mortality is where things get really interesting, and complex.

Speaker 1Exactly. On one hand, chronic, unrelieved pain itself is a known accelerator of biological aging. We see this in studies like one in *GeroScience* from 2025, PMID 39847262, which found painful diabetic neuropathy linked to accelerated epigenetic aging and telomere shortening compared to painless neuropathy. So, treating pain could theoretically slow down some aspects of aging.

Speaker 2That's a crucial point. However, the evidence specifically on trigger point injections and their direct impact on biological aging or all-cause mortality is still quite limited. We don't have large, long-term studies showing these injections, by themselves, extend lifespan or reverse epigenetic aging.

Speaker 1And what about potential long-term risks associated with frequent or ongoing use? While generally safe when appropriately used, any intervention has considerations.

Speaker 2Absolutely. For trigger point injections, direct harms like falls, sedation, or dependence are less common compared to, say, oral opioids. But we lack robust data on their long-term effects on cognitive function or cardiovascular health. The benefit of pain relief needs to be weighed against the unknown long-term implications, especially for biological aging markers.

Speaker 1So, it's a balance. Treating pain is vital, and these injections can be effective for many. But the direct evidence on their impact on biological aging or mortality markers like the epigenetic clock is still unestablished. More research is definitely needed here.